Nasal vaccine devices have the potential to offer more convenient and more effective protection against a variety of viruses.

Using glucocorticoids, rituzimab, or certain immunosuppressants to treat connective tissue diseases is associated with greater risks for severe COVID-19-related outcomes.

CSL (CSLLY) and Arcturus Therapeutics (ARCT) announced that the European Commission has granted marketing authorization for Kostaive, a ...

The US is in the throes an unusually intense and severe flu season, with hospitalization rates topping the levels seen with ...

RALEIGH — The North Carolina Department of Health and Human Services is reporting two pediatric flu-related deaths, the first for the 2024-2025 flu season.

Our immune systems rely on iron to function, but so do invading viruses and bacteria. New research from Binghamton University ...

The Tehama County Health Services Agency, Public Health, strongly encourages everyone who has not yet received a flu vaccine ...

Flu continues to be one of the most common and alarming seasonal illnesses. In the period spanning from 2023 to 2024, there ...

Two children have died of flu in North Carolina, according to the North Carolina Department of Health and Human Services.

The molecule is also being tested in over 100 vaccine clinical trials. Rising QS-21 demand from the pharmaceutical industry ...

The North Carolina Department of Health and Human Services is reporting two pediatric flu-related deaths, the first for the 2024-2025 flu season. One child in the Eastern region and another in the ...

The intense debate over President Donald Trump’s nominee to head the Department of Health and Human Services, Robert F.